Hamakyorex Co., Ltd. (TYO:9037)
Japan
· Delayed Price · Currency is JPY 1,296.00
-5.00 (-0.38%)
Mar 10, 2025, 3:30 PM JST
Hamakyorex Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 146,492 | 140,572 | 131,912 | 125,094 | 118,876 | 122,471 | Upgrade
|
| Revenue Growth (YoY) | 6.87% | 6.56% | 5.45% | 5.23% | -2.94% | 5.65% | Upgrade
|
| Cost of Revenue | 128,118 | 123,138 | 116,448 | 110,286 | 104,960 | 108,812 | Upgrade
|
| Gross Profit | 18,374 | 17,434 | 15,464 | 14,808 | 13,916 | 13,659 | Upgrade
|
| Selling, General & Admin | 4,452 | 4,329 | 3,429 | 3,220 | 2,869 | 3,006 | Upgrade
|
| Other Operating Expenses | 534 | 534 | 485 | 474 | 465 | 462 | Upgrade
|
| Operating Expenses | 4,977 | 5,089 | 3,915 | 3,694 | 3,353 | 3,468 | Upgrade
|
| Operating Income | 13,397 | 12,345 | 11,549 | 11,114 | 10,563 | 10,191 | Upgrade
|
| Interest Expense | -176 | -149 | -138 | -142 | -146 | -158 | Upgrade
|
| Interest & Investment Income | 129 | 129 | 99 | 75 | 58 | 60 | Upgrade
|
| Other Non Operating Income (Expenses) | 748 | 687 | 686 | 835 | 403 | 444 | Upgrade
|
| EBT Excluding Unusual Items | 14,098 | 13,012 | 12,196 | 11,882 | 10,878 | 10,537 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 131 | -24 | 12 | 158 | -14 | Upgrade
|
| Gain (Loss) on Sale of Assets | 192 | 122 | 109 | 74 | 34 | 465 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -151 | Upgrade
|
| Legal Settlements | -10 | -24 | - | -146 | - | - | Upgrade
|
| Other Unusual Items | 178 | 205 | -45 | -17 | -161 | -17 | Upgrade
|
| Pretax Income | 14,458 | 13,446 | 12,236 | 11,805 | 10,909 | 10,820 | Upgrade
|
| Income Tax Expense | 4,402 | 4,211 | 3,928 | 3,714 | 3,536 | 3,565 | Upgrade
|
| Earnings From Continuing Operations | 10,056 | 9,235 | 8,308 | 8,091 | 7,373 | 7,255 | Upgrade
|
| Minority Interest in Earnings | -1,024 | -930 | -908 | -974 | -946 | -1,022 | Upgrade
|
| Net Income | 9,032 | 8,305 | 7,400 | 7,117 | 6,427 | 6,233 | Upgrade
|
| Net Income to Common | 9,032 | 8,305 | 7,400 | 7,117 | 6,427 | 6,233 | Upgrade
|
| Net Income Growth | 16.63% | 12.23% | 3.98% | 10.74% | 3.11% | 5.55% | Upgrade
|
| Shares Outstanding (Basic) | 75 | 75 | 75 | 75 | 75 | 76 | Upgrade
|
| Shares Outstanding (Diluted) | 75 | 75 | 75 | 75 | 75 | 76 | Upgrade
|
| Shares Change (YoY) | -0.66% | -0.11% | -0.00% | -0.12% | -1.02% | -0.00% | Upgrade
|
| EPS (Basic) | 121.07 | 110.63 | 98.47 | 94.71 | 85.42 | 81.99 | Upgrade
|
| EPS (Diluted) | 121.07 | 110.63 | 98.47 | 94.71 | 85.42 | 81.99 | Upgrade
|
| EPS Growth | 17.41% | 12.35% | 3.98% | 10.87% | 4.18% | 5.56% | Upgrade
|
| Free Cash Flow | - | 7,667 | 11,301 | 8,109 | 4,582 | 7,600 | Upgrade
|
| Free Cash Flow Per Share | - | 102.13 | 150.38 | 107.91 | 60.90 | 99.97 | Upgrade
|
| Dividend Per Share | 32.500 | 30.000 | 23.750 | 21.250 | 18.750 | 17.500 | Upgrade
|
| Dividend Growth | 23.81% | 26.32% | 11.76% | 13.33% | 7.14% | 7.69% | Upgrade
|
| Gross Margin | 12.54% | 12.40% | 11.72% | 11.84% | 11.71% | 11.15% | Upgrade
|
| Operating Margin | 9.15% | 8.78% | 8.76% | 8.88% | 8.89% | 8.32% | Upgrade
|
| Profit Margin | 6.17% | 5.91% | 5.61% | 5.69% | 5.41% | 5.09% | Upgrade
|
| Free Cash Flow Margin | - | 5.45% | 8.57% | 6.48% | 3.85% | 6.21% | Upgrade
|
| EBITDA | 19,653 | 18,326 | 17,163 | 16,563 | 15,828 | 15,381 | Upgrade
|
| EBITDA Margin | 13.42% | 13.04% | 13.01% | 13.24% | 13.31% | 12.56% | Upgrade
|
| D&A For EBITDA | 6,256 | 5,981 | 5,614 | 5,449 | 5,265 | 5,190 | Upgrade
|
| EBIT | 13,397 | 12,345 | 11,549 | 11,114 | 10,563 | 10,191 | Upgrade
|
| EBIT Margin | 9.15% | 8.78% | 8.76% | 8.88% | 8.89% | 8.32% | Upgrade
|
| Effective Tax Rate | 30.45% | 31.32% | 32.10% | 31.46% | 32.41% | 32.95% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.